Zentalis Pharmaceuticals Appoints Kimberly Freeman as Chief Strategy Officer
Go back to Zentalis Pharmaceuticals Appoints Kimberly Freeman as Chief Strategy Officer| (NASDAQ: ZNTL) | Delayed: 3.77 +0.21 (5.90%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.56 | 52 Week High | $ | |||
| Open | $3.56 | 52 Week Low | $ | |||
| Day High | $3.85 | P/E | N/A | |||
| Day Low | $3.54 | EPS | $ | |||
| Volume | 1,212,361 | |||||

